Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

Similar articles for PubMed (Select 22010534)

1.

Live attenuated influenza vaccine--a review.

Gasparini R, Amicizia D, Lai PL, Panatto D.

J Prev Med Hyg. 2011 Sep;52(3):95-101. Review.

PMID:
22010534
2.
3.

[Live cold-adapted influenza vaccine: state-of-the-art].

Gendon IuZ.

Vopr Virusol. 2011 Jan-Feb;56(1):4-17. Review. Russian.

PMID:
21427948
4.

A randomized, double-blind study of the safety, transmissibility and phenotypic and genotypic stability of cold-adapted influenza virus vaccine.

Vesikari T, Karvonen A, Korhonen T, Edelman K, Vainionpää R, Salmi A, Saville MK, Cho I, Razmpour A, Rappaport R, O'Neill R, Georgiu A, Gruber W, Mendelman PM, Forrest B; CAIV-T Transmission Study Group.

Pediatr Infect Dis J. 2006 Jul;25(7):590-5.

PMID:
16804427
5.

Influenza vaccines in children.

Neuzil KM, Edwards KM.

Semin Pediatr Infect Dis. 2002 Jul;13(3):174-81. Review.

PMID:
12199613
7.

Live attenuated versus inactivated influenza vaccine in infants and young children.

Belshe RB, Edwards KM, Vesikari T, Black SV, Walker RE, Hultquist M, Kemble G, Connor EM; CAIV-T Comparative Efficacy Study Group.

N Engl J Med. 2007 Feb 15;356(7):685-96. Erratum in: N Engl J Med. 2007 Mar 22;356(12):1283.

8.

Comparative efficacy of inactivated and live attenuated influenza vaccines.

Monto AS, Ohmit SE, Petrie JG, Johnson E, Truscon R, Teich E, Rotthoff J, Boulton M, Victor JC.

N Engl J Med. 2009 Sep 24;361(13):1260-7. doi: 10.1056/NEJMoa0808652.

9.

Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine.

Belshe RB, Gruber WC, Mendelman PM, Cho I, Reisinger K, Block SL, Wittes J, Iacuzio D, Piedra P, Treanor J, King J, Kotloff K, Bernstein DI, Hayden FG, Zangwill K, Yan L, Wolff M.

J Pediatr. 2000 Feb;136(2):168-75.

PMID:
10657821
10.
11.
12.

Seasonal influenza vaccines.

Fiore AE, Bridges CB, Cox NJ.

Curr Top Microbiol Immunol. 2009;333:43-82. doi: 10.1007/978-3-540-92165-3_3. Review.

PMID:
19768400
13.

Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.

Desheva JA, Lu XH, Rekstin AR, Rudenko LG, Swayne DE, Cox NJ, Katz JM, Klimov AI.

Vaccine. 2006 Nov 17;24(47-48):6859-66. Epub 2006 Jun 28.

PMID:
17050041
14.

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.

Belshe RB, Mendelman PM, Treanor J, King J, Gruber WC, Piedra P, Bernstein DI, Hayden FG, Kotloff K, Zangwill K, Iacuzio D, Wolff M.

N Engl J Med. 1998 May 14;338(20):1405-12.

15.

The role of live influenza vaccines in children.

Gruber WC.

Vaccine. 2002 May 15;20 Suppl 2:S66-73.

PMID:
12110263
16.
17.
18.

Cold-adapted, live attenuated influenza vaccine.

Glezen WP.

Expert Rev Vaccines. 2004 Apr;3(2):131-9. Review.

PMID:
15056039
19.

Immunization of institutionalized asthmatic children and patients with psychomotor retardation using live attenuated cold-adapted reassortment influenza A H1N1, H3N2 and B vaccines.

Miyazaki C, Nakayama M, Tanaka Y, Kusuhara K, Okada K, Tokugawa K, Ueda K, Shibata R, Nishima S, Yamane N, et al.

Vaccine. 1993;11(8):853-8.

PMID:
8356846
20.

Cold-adapted influenza vaccines.

Bradshaw J, Wright PF.

Curr Opin Pediatr. 2002 Feb;14(1):95-8. Review.

PMID:
11880742
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk